Published: Thu, November 24, 2016
Economy | By Melissa Porter

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Has An Impact Score Of 100

Royal Bank of Canada now owns 1,983,749 shares of the information technology service provider's stock worth $124,382,000 after buying an additional 1,158,887 shares during the period. Blackrock accumulated 1.33 million shares or 0.11% of the stock. The company has total market value of 32.26B. Its last 5-Year EPS growth stands at 17.40%; with earnings growth of 12.70% yoy.

When the current quarter ends, Wall Street expects Cognizant Technology Solutions Corporation to have earnings per share of $0.87.

The firm is trading with SMA20 of 12.76 Percent, SMA50 of 26.57 Percent and SMA200 of 42.25 percent. Similarly, the company has Return on Assets of 0.7 percent, Return on Equity of 6.6 percent and Return on Investment of 9.1 Percent.

The company shows its Return on Assets (ROA) value of 11.9%. One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. Stock monthly performance is recorded as 1.39% while its performance in last 5 sessions is 1.63%.

Brocade Communications Systems, Inc. now has mean rating of 3.10 while 0 analysts have commented the shares as "BUY", 0 recommended as "OUTPERFORM" and 15 commented as "HOLD".

Additionally, the company has EPS of 1.24. The share price of $53.18 is at a distance of 17.03 percent from its 52-week low and down -18.72 percent versus its peak.

Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date.

09/30/2016 - HSBC began new coverage on Cognizant Technology Solutions Corporation giving the company a "buy" rating. The Company's competencies include business, process, operations and IT consulting, application development and systems integration, enterprise information management, application testing, application maintenance and IT infrastructure services.

Receive Cognizant Technology Solutions Corporation News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognizant Technology Solutions Corporation with's FREE daily email newsletter. They now have a United States dollars 70 price target on the stock.

Insider Transactions: Since June 3, 2016, the stock had 0 insider purchases, and 12 selling transactions for $33.34 million net activity. The stock has a market capitalization of $34.35B along with 606.70M outstanding shares.

The stock is going forward its fifty-two week low with 35.68% and lagging behind from its 52-week high price with -1.68%. Cognizant Technology Solutions Corp (NASDAQ:CTSH) has declined 11.44% since April 21, 2016 and is downtrending. They now own 506.90 million shares or 5.36% less from 535.62 million shares in 2016Q1.

In related news, CFO Karen Mcloughlin sold 10,000 shares of the company's stock in a transaction on Tuesday, November 1st.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) went lower by -0.85% to close at $ 55.10. The difference between the actual and Estimated EPS is $0.02. The stock has performed 2.13% over the last seven days, 10.84% over the last thirty, and -5.25% over the last three months. Year to Date performance value (YTD perf) value is -8.2%. If a company's earnings are much lower than expected, the company's stock may gap down before the next trading session. Volatility for the week appears to be 2.76% in conjunction with the Volatility for the month at 2.17%.

Taking a brief view of stock performance, we see that company shares are now trading $3.27 off the 50-day moving average of $51.71 and $-1.73 off of the 200-day moving average of $56.71.

The Company now has ROA (Return on Assets) of 11.9 percent, Return on Equity (ROE) of 16 Percent and Return on Investment (ROI) of 15.2% with Gross margin of 40.4 percent and Operating & Profit margin of 17.2% and 11.8% respectively.

Like this: